Evidence map›Paper›PMID 40485706›Full record

ArticleKidney international reports2025

Interaction Between

Kullaya Takkavatakarn, Dinushika Mohottige, Alexander W Charney, Carol Horowitz, Andrew G Rundle, Lili Chan, Girish N Nadkarni

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney international reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kullaya TakkavatakarnDivision of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Dinushika MohottigeDivision of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Alexander W CharneyThe Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Carol HorowitzDepartment of Population Health and Policy, Institute for Health Equity Research, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Andrew G RundleDepartment of Epidemiology, Columbia University Mailman School of Public Health, New York, New York, USA.
Lili ChanDivision of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Girish N NadkarniDivision of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Funding

Elucidating Genetic and Environmental Second Hits in Racial and Ethnic Minorities with APOL1 High-Risk GenotypesR01DK127139 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI NADKARNI, GIRISH NITIN · 2021 to 2025
$4.0M
Structural Racism as a "Third hit" on kidney outcomes of Black individuals with APOL1 risk allelesK23DK139454 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Dinushika Mohottige · 2024 to 2026
$583k
NIDDK NIH HHS K23 DK139454NIDDK NIH HHS R01 DK127139
6 · The paper itself

Abstract

Introduction: Apolipoprotein L1 ( Methods: This retrospective study included self-reported Black individuals with genetic, clinical, and residential data. We defined the neighborhood as a 1 km Results: Of 4296 participants, 829 (19%) had the composite kidney outcome; 20% with and 9% without the composite outcome had Conclusion: Significant interactions between

Indexed as

APOL1gene-environment interactionkidney outcomemedian household incomeneighborhood socioeconomic statuspoverty rate

Identifiers

PMID40485706
PMCPMC12142791

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.